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In cystic fibrosis (CF), perturbations of total daily energy expenditure (TDEE) may be a major determinant of altered nutrition and
growth. Measurement of TDEE is problematic, though the flex-heart rate method (FHRM) provides a close estimation of TDEE, as compared
to the cost-prohibitive, gold standard, the double-labeled water method, and permits estimates of the energy cost of daily activities (ECA)
above resting energy expenditure (REE). We hypothesize that alterations in ECA affects TDEE in CF.
Purpose: To measure components of TDEE in adolescents with CF and normal lung function compared with controls, and to determine
whether ECA can be improved by diet and exercise.
Methods: Clinically stable CF subjects (aged 9–13, n =12) and age- and gender-matched controls (n =13) had repeated measurements of
TDEE by FHRM, REE, and maximal cardiopulmonary exercise testing (CPET) during a 6-week exercise and diet program.
Results: While the mean REE was similar in both groups, ECA was significantly lower in CF adolescents as compared to controls
( p =0.02). During CPET, maximal exercise in CF was characterized by hyperventilation, which was unrelated to ventilation–perfusion
mismatching. There were no changes in REE after dietary intervention.
Conclusion: ECA in CF adolescents with normal lung function is lower when compared to healthy controls. These findings support the
hypothesis that clinically stable patients with CF have inefficient energy metabolism or alternatively conserve energy during activities of
daily living.
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Cystic fibrosis (CF) is the most common lethal genetic
disease in Caucasians. Its adverse impact on nutritional status
is well recognized. Several studies have identified a strong
relationship between malnutrition and mortality [1,2]. Nutri-
tional deficiencies are related to alterations in energy
metabolism in persons who have CF, which are multi-
factorial. Low energy intake, decreased energy absorption
and increased energy expenditure are all documented in CF1569-1993/$ - see front matter D 2005 European Cystic Fibrosis Society. Publish
doi:10.1016/j.jcf.2005.10.001
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E-mail address: shepherd_r@kids.wustl.edu (M.R. Johnson).patients [3]. In particular, resting energy expenditure (REE)
appears to be increased per unit cell mass in malnourished
children with CF [4–8], which cannot be completely
explained by pulmonary inflammation [4]. Nevertheless,
the later development of abnormal pulmonary mechanics
may cause further increases with age [5–8].
Knowledge of REE alone provides only an incomplete
assessment of total daily energy expenditure (TDEE), and
does not provide any information regarding the energy cost of
daily activities (ECA), which may be an important contrib-
utor to altered energy balance in diseases such as CF. The
development of the doubly-labeled water (DLW) technique
has permitted determination of TDEE in free living humans,
and early studies in CF have showed either normal [9] or
increased [10] TDEE in this disease. At present, however, the
cost of the DLW method is prohibitive and DLW iss 5 (2006) 53 – 58ed by Elsevier B.V. All rights reserved.
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by flex-heart rate method (FHRM), activity diaries or
accelerometry. Of available alternatives to DLW, the FHRM
provides the closest estimation of TDEE, and has the
advantage of providing information on ECA. Indeed, the
FHRM has been validated against the DLWby Livingstone et
al. [11]. The FHRM relies on the physiological relationship
between heart rate (HR) and activity, and the fact that this
increase is closely relate to EE above resting levels. The
technique involves measuring REE, and deriving individual
correlation of HR to EE over five energy levels of activity.
TDEE can then be calculated from the resultant regression
equations [11,12], and 24-h heart rate monitoring. The ECA
for a 24-h day can then be calculated from the TDEE and
REE.
In this study, we report findings with respect to TDEE,
REE, ECA and maximal cardiopulmonary exercise testing of
clinically stable CF adolescents with normal lung function.
We hypothesized that in healthy CF patients, compared to
controls, that the ECA is altered due to inefficiencies of
energy metabolism during activities such as exercise. In
addition, we studied the potential for improving energy
efficiency of activity by an exercise and diet program, such as
that observed in athletes undergoing intensive training.2. Methods
2.1. Subjects
Clinically stable persons with CF (n =12), aged 8–21
were recruited from the Washington University Cystic
Fibrosis Center at Saint Louis Children’s Hospital. Healthy
age-, gender-, and developmentally-matched controls
(n =13) were recruited from the community. Enrollment
criteria included: ability to perform CPET, forced expiratory
volume at 1 s (FEV1) consistently greater than 50% for the 2
years before to enrollment, no history of diabetes, liver
dysfunction or hepatosplenomegaly, and no contraindication
to participation based on pre-participation screening. Patients
were not studied during an active pulmonary exacerbation.
Informed written consent was obtained form each participant
and their parents, and the studies were approved by the
Washington University School of Medicine Human Studies
Committee.
2.2. Design
All patients and controls had initial REE and TDEE
determined using the FHRM and maximal CPET testing.
Persons with CF were evaluated on 3 occasions, while
controls were evaluated only once during the study period. At
the time of enrollment, clinical data was obtained and no
interventions were performed during a 6-week wash-in
period to assess repeatability of measurements. During the
second phase, the participants were randomized to either: (a)a graded exercise program combined with carbohydrate
supplements or (b) a graded exercise program combined with
fat supplements. Supplements equaled 50% of their REE.
Patients on the carbohydrate arm of the study received
RESOURCE\ Fruit Beverage supplement. Participants on
the fat arm received Scandishakes\ with cream so that the
supplement had at least 50% lipid content. The exercise
program was supervised three times weekly for 6 weeks.
Exercise was individualized to the participant and was
entirely aerobic. Sessions were monitored by a member of
the research team. A heart rate equal to 60% of the HRmax was
sought during these sessions which lasted 45–60 min. At
initiation and completion of the 6-week exercise program, the
studies were repeated and EE re-measured.
2.3. REE and FHRM
Fasting REE was determined in the early morning with a
metabolic cart (Sensormedics 2900) by measuring expiratory
oxygen uptake (VO2), carbon dioxide excretion (VCO2) over a
20–40 min period. The manual radial pulse was measured
every 5 min. After measurement of REE, participants had a
standardized snack (one Nutrigrain bar* per 20 kg weight
and 8 oz whole milk). They were then asked to perform
routine spirometry including forced vital capacity (FVC),
and FEV1. Participants were then fitted with electrocardio-
graph monitoring equipment, a headset and mouthpiece for
measurements of heart rate (by EKG), VCO2, VO2, respiratory
quotient (RQ), and EE/m (as calculated by Weir equation)
within the Sensormedics 2900 metabolic cart. Participants
then proceeded to perform a 5-Step activity program where
they exercised 5 min at 5 separate levels of activity (sitting,
standing, and progressive walking (1, 2, and 2 MPH with 3%
grade). Values were time averaged by 30 s.
2.4. Maximal CPET
After obtaining the 5-step activities, the participants were
then encouraged to progress through an exercise protocol on a
Sensormedics 800S cycle ergometer starting at 0Wresistance
for 3 min then progressing by 10 W/min until VO2max was
obtained. VO2, VCO2, (Ve), end-tidal O2 (ETO2), and end-tidal
CO2 (ETCO2)work, and HR (by EKG) were measured.
2.5. TDEE and ECA
After testing, the ‘‘flex point’’ (defined as the average of
the highest resting heart rate and lowest activity heart rate)
was determined. Linear regression of HR versus EE/m above
the ‘‘flex point’’ was calculated using the least squares
method by SPSS software. HR data was then measured for
24–72 h using a Polar 610 heart rate monitor (Polar Electro,
Kempele, Finland). This consists of an electronic chest strap
transmitter and wrist watch where heart rate data is stored in a
memory to be later downloaded to a personal computer for
analysis. TDEEwas then calculated based on the downloaded
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Fig. 1. Measured energy expenditure in cystic fibrosis adolescents. The
mean REE (white columns) was similar between healthy CF and non-CF
M.R. Johnson et al. / Journal of Cystic Fibrosis 5 (2006) 53–58 55HR data using the FHRM. EE below the flex point was
calculated as being equal to REE. EE above the flex point was
calculated from the regression equation relating HR to EE/m.
The ECAwas calculated as the difference between TDEE and
REE.
2.6. Statistical analyses
Differences between patients and controls at end exercise
were analyzed by comparing the means for measured values,
and p-values less than 0.05 were considered statistically
significant. Differences in study results (except for end
exercise data) between: CF patient and control groups were
analyzed using standard student T-tests. Calculation of the
best fit straight line correlating EE/m to HR (for HR values
greater than the ‘‘flex point’’), was performed using the ‘‘least
squares’’ method.
adolescents (1393 calories/day and 1290 calories/day, respectively;
p =0.17). In contrast, the mean ECA (gray columns) in CF adolescents
was significantly lower compared to non-CF subjects (267 calories/day and
769 calories/day, respectively; p =0.02).
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ECA3. Results
For enrollment, we had broad inclusionary criteria and
sought to recruit persons with CF from 8 to 21 with mild and
moderate lung disease. Despite this we were only able to
recruit CF patients who were all 9–13. All had normal lung
function and mild pulmonary disease. The characteristics of
study are given in Table 1. Of the 12 subjects with CF
enrolled into the study, 10 subjects completed the entire study
and 2 subjects (both males) withdrew from the study after the
first exercise testing session. One subject with CF had non-
physiologic results (i.e., TDEE=5730 calories/day) and was
excluded from analysis. 21 controls were enrolled and of
these 8 had completed puberty and were excluded from
analysis to match the recruited CF participants. These 13 age-
, gender-, and Tanner stage-matched controls were compared
to our CF population.
176 of 180 exercise sessions were supervised by amember
of the research team. Of the 4 missed sessions compliance of
the sessions was verified with a heart rate monitor.
Compliance with the use of the supplements was verified
during the supervised exercise sessions.
Heart rate data was collected for 24–72 h every 15 s. We
experienced difficulties with a newly remanufactured chest
strap that was stiffer than previous models and conformed
poorly to smaller chests (i.e., children). We recollected data if
recordings were inadequate. Data points were downloadedTable 1
CF Control P value
M:F 6:5 8:5 0.74
Age (years) 12.7 11.2 0.10
Bone age (years) 12.1 10.2 0.11
Tanner (pubic hair) 2.9 2.5 0.53
Wt (kg) 44.3 43.3 0.84
Ht (m) 1.50 1.46 0.52
BMI (kg/m2) 19.6 19.9 0.84
FEV1 (% predicted) 103 106 0.69into an excel spreadsheet and averaged for time of day (i.e.,
data for 01:10.15 was averaged with 01:10:15 data for the
next day and 16:58:45 was averaged with 16:58:45). The
averaged data was used for analysis of TEE by the heart rate
method.
Values for REE and ECA are shown in Fig. 1. Mean REE
was 1393 calories/day in CF and 1290 calories/day in our
control population, which was not statistically significant
( p =0.17). However, the mean ECAwas different in healthy
CF adolescents compared to control subjects (267 calories/
day and 769 calories/day, respectively; p =0.02). There were
no statistically or clinically significant changes in EE after
intervention with diet and exercise (see Fig. 2).0
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Fig. 2. Measured energy expenditure in cystic fibrosis adolescents
following dietary and exercise interventions. CF patients began a
monitored, six-week exercise program after they were randomized to either
carbohydrate or lipid supplementation groups. Both REE (white columns)
and ECA (gray columns) were measured before and after interventions.
There were no significant changes in EE after intervention with exercise
and either dietary regimen.
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in Fig. 3. Maximum VO2 was higher in controls but when
corrected for height (based on established norms for height,
[13]) was similar (Fig. 3a). Ve (Fig. 3b), RQ (Fig. 3c) and
VeO2 (Fig. 3d) were consistently higher in individuals with
CF. These findings suggest that those with CF hyperventi-
late during exercise (compared with controls) to obtain a
similar VO2. ETO2 (Fig. 3e) was higher and ETCO2 (Fig. 3f)
lower in our population of patients with CF (with normal
lung function) suggesting that any hyperventilation seen in
this population of CF patients was not a result of V/Q
mismatching.
In summary, maximal exercise in this population of
patient with CF was characterized by a degree of hyper-
ventilation (increased Ve, RQ and VeO2) that did not appear
to be the result of ventilation–perfusion mismatching.
Despite this, maximal oxygen uptake is similar between
individuals with CF and controls.Ve
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Fig. 3. Exercise characteristics of persons with cystic fibrosis. The exercise charac
expiratory oxygen uptake (VO2) was similar between CF adolescents ( ) and non
quotient (RQ); and (d) ventilatory equivalent for oxygen (VeO2) were consistently h
during exercise as compared to controls to obtain a similar VO2. (e) End tidal oxyge
with CF indicating that hyperventilation observed in this healthy CF population w4. Discussion
In this study, we found that CF adolescents with normal
pulmonary function controls had lower ECA than healthy
controls. REE was not elevated overall in the CF patients,
contrary to some, but not all, earlier studies, though
alterations in body composition (lower cell mass in CF,
expanded extracellular water, without changes in total body
weight) may explain this finding [4]. The ECA of a 24-h day
is a function of the intrinsic metabolism of the individual
and the amount of activity the individual partakes. We did
not measure activity so it is unclear if our subjects with CF
had less activity (which we suspect) or had an intrinsic
metabolic difference from controls. It is possible that there is
bioconservation of overall energy expenditure with a
reduction in spontaneous activity. Alternatively, CF patients
may simply be relatively inactive due to other limitation
from their disease. If alterations in metabolism are-60 -50 -40 -30 -20 -10 0
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teristics of CF adolescents were measured as described in Methods. (a) The
-CF subjects ( ); while (b) carbon dioxide excretion (VCO2); (c) respiratory
igher in CF adolescents, which suggested that CF individuals hyperventilate
n (ETO2) is higher, and (f) end tidal carbon dioxide (ETCO2,) is lower in those
ith normal lung function was not a result of V/Q mismatching.
M.R. Johnson et al. / Journal of Cystic Fibrosis 5 (2006) 53–58 57suspected, we suggest future studies either study energy
metabolism of standardized activities such as those de-
scribed by Richard et al. [14], or quantitate activity with a
measure such as accelerometry.
We were unsuccessful in changing EE by dietary
manipulation and exercise during this 6-week trial. We
based our intervention on the concept of ‘‘fat adaptation’’
wherein normal individuals are able to increase lipid usage
by a combination of cardiovascular exercise and a high fat
diet [15–17]. Unlike these studies in healthy persons, where
the intrinsic RQ of the individuals decreased, our CF
patients randomized to lipid supplements had no change in
the resting RQ measured during determination of REE. Our
inability to achieve ‘‘fat adaptation’’ may have been a result
of inadequate lipid absorption or inadequate lipid intake per
day. Alternatively, during our supervised exercise sessions,
we may have been unsuccessful in achieving the level of
exercise as is needed to achieve fat adaptation.
Similar to previous studies [18,19], we noted that
individuals with CF studied at maximal exercise had a
higher degree of ventilation compared with similar controls.
The degree of ventilation did not seem to be a result of
ventilation–perfusion mismatching which was suggested by
other studies. Our population had normal lung function as
measured by FEV1 (average 102%, range 82–125%
predicted) so it is unlikely that they had significantly
increased dead space ventilation. Likewise, ETO2 increased
and ETCO2 decreased at end exercise, which argues against
ventilation–perfusion mismatch playing a dominant role in
hyperventilation. Other causes of the elevated Ve could
include voluntary hyperventilation or metabolic differences
intrinsic to CF.
In both CF and control subjects, increased activity is
chiefly fueled by greater utilization of carbohydrates. In
addition, normal individuals are able to increase their use of
lipids as an energy source during exercise [15–17,20] and
exercise programs are able to increase the intrinsic beta-
oxidation of lipids [20]. If, as we suspect, there is impaired
in lipid utilization in CF patients, any increase in activity
would have to be fueled by increased carbohydrate
utilization. This utilization of carbohydrates would in turn
increase VCO2, Ve and the RQ. Indeed, we demonstrated all
these characteristics during our study. This may be a basis
for the inefficiency in mitochondrial oxidation [21,22]
which has also been described in persons with CF.
Likewise, there appears to be impaired muscle function
in CF. Specifically, there are work limitations in persons
with CF even when adjusted for muscle mass [23] or when
similar control populations are recruited [22]. If as we
suspect, beta-oxidation of lipids is impaired in CF, this
inefficiency may contribute to a decreased ability perform
work in those with CF.
Finally, we had hypothesized that impairments in energy
metabolism could be corrected by exercise and increased fat
supplementation, but we were unable to demonstrate
changes in EE with such interventions. This failure maybe because a) our underlying hypothesis that alterations in
EE could be improved by fat supplementation and exercise
was incorrect, b) our intervention was insufficient to
demonstrate a positive effect, or c) the problem is intrinsic
to those with CF and cannot be corrected by simple
intervention (i.e., diet and exercise). If there is an intrinsic
defect in lipid metabolism in those with CF, it likely plays a
role in the malnutrition that occurs in CF. Similarly,
alterations in energy metabolism may cause individual with
CF to fatigue quicker than peers, further decreasing activity.
Clearly, additional studies into role of lipid metabolism in
CF are needed to better understand these findings.Acknowledgements
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